PITTSBURGH, July 29, 2019 (GLOBE NEWSWIRE) -- II-VI Incorporated (IIVI) today announced that it intends to hold a live webcast and conference call on Tuesday, August 13, 2019, at 9:00 a.m. EDT to review the Company’s fiscal 2019 fourth quarter and fiscal year end results for the period ended June 30, 2019. The call will be hosted by Mary Jane Raymond, Chief Financial Officer, and Dr. Vincent D. (Chuck) Mattera, Jr., Chief Executive Officer.
The fourth quarter and fiscal year end results will be released before the market opens on Tuesday, August 13, 2019, and will be posted on the Company’s web site at www.ii-vi.com/investor-relations.
Conference call numbers:
If you wish to participate in the conference call, please dial (877) 316-5288 for U.S. calls, and (734) 385-4977 for international calls. To join the conference call, please enter ID# 1286517, then provide your name and company affiliation.
Conference call replay:
The conference call will be recorded, and a replay will be available to interested parties who are unable to attend the live call. This service will be available until 11:59 p.m. EDT on Friday, August 16, 2019, by dialing (855) 859-2056 for U.S. calls and (404) 537-3406 for international calls, and entering ID# 1286517.
About II-VI Incorporated
II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial, optical communications, military, life sciences, semiconductor equipment, and consumer markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at www.ii-vi.com.
This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction with Finisar Corporation (“Finisar”) and the anticipated benefits thereof. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. Important factors that may cause such a difference include but are not limited to: (i) the ability of II-VI and Finisar to complete their proposed transaction on the anticipated terms and timing or at all; (ii) the ability of the parties to satisfy the conditions to the closing of the proposed transaction, including obtaining required regulatory approvals; (iii) potential litigation relating to the proposed transaction, which could be instituted against II-VI, Finisar, or their respective directors; (iv) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction; (v) the triggering of any third-party contracts containing consent and/or other similar provisions; (vi) any negative effects of the announcement of the transaction on the market price of Finisar’s common stock and/or negative effects of the announcement or commencement of the transaction on the market price of II-VI’s common stock; (vii) any negative effects of the commencement of the proposed transaction on the market price of II-VI’s common stock; (viii) uncertainty as to the long-term value of II-VI’s common stock and thus the value of the II-VI shares to be issued in the proposed transaction; (ix) any unexpected impacts from unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, and losses on the future prospects, business, and management strategies for the management, expansion, and growth of the combined company’s operations after the consummation of the proposed transaction and on the other conditions to the completion of the merger; (x) inherent risks, costs, and uncertainties associated with integrating the businesses successfully and achieving all or any of the anticipated synergies related to the proposed transaction; (xi) potential disruptions from the proposed transaction that may harm II-VI or Finisar’s respective businesses, including current plans and operations; (xii) the ability of II-VI and Finisar to retain and hire key personnel; (xiii) adverse legal and regulatory developments or determinations or adverse changes in, or interpretations of, U.S. or foreign laws, rules, or regulations that could delay or prevent completion of the proposed transaction or cause the terms of the proposed transaction to be modified; (xiv) the ability of II-VI to obtain or consummate financing or refinancing related to the transaction upon acceptable terms or at all; (xv) economic uncertainty due to monetary or trade policy, political, or other issues in the United States or internationally; (xvi) any unexpected fluctuations or weakness in the U.S. and global economies; (xvii) changes in U.S. corporate tax laws as a result of the Tax Cuts and Jobs Act of 2017 and any future legislation; (xviii) foreign currency effects on II-VI or Finisar’s respective businesses; (xix) competitive developments, including pricing pressures, the level of orders that are received and can be shipped in a quarter, changes or fluctuations in customer and end-user order patterns, and seasonality; (xx) changes in the utilization of II-VI or Finisar’s manufacturing capacity and II-VI’s ability to effectively manage and expand its production levels; (xxi) the timely release of new products and acceptance of such new products by the market; (xxii) the introduction of new products by competitors and other competitive responses; (xxiii) II-VI’s ability to assimilate recently acquired businesses and risks, costs, and uncertainties associated with such acquisitions; (xxiv) II-VI’s ability to achieve the anticipated benefits of capital investments that it makes; (xxv) the ability of II-VI to devise and execute strategies to respond to market conditions; (xxvi) disruptions in II-VI’s business or the businesses of its customers or suppliers due to natural disasters, terrorist activity, armed conflict, war, worldwide oil prices and supply, public health concerns, or disruptions in the transportation system; (xxvii) the responses by the respective managements of II-VI and Finisar to any of the aforementioned factors; and (xxviii) the failure of any one or more of the assumptions stated above to prove to be correct. Additional risks are described under the heading “Risk Factors” in II-VI’s Annual Report on Form 10-K for the year ended June 30, 2018, filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 28, 2018, and in Finisar’s Annual Report on Form 10-K for the year ended April 28, 2019, filed with the SEC on June 14, 2019.
These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the joint proxy statement/prospectus included in the registration statement on Form S-4 (File No. 333-229052) filed with the SEC in connection with the proposed transaction (the “Form S-4”). While the list of factors discussed above is, and the list of factors presented in the Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Neither II-VI nor Finisar assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.